Sally A. Hulton
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory.
Journal: Kidney international reports
Published: July 02, 2024
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients.
Journal: Clinical kidney journal
Published: February 09, 2022
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1.
Journal: Kidney international reports
Published: November 12, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Journal: The New England journal of medicine
Published: March 31, 2021
An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Journal: Kidney international
Published: March 02, 2021
Combined liver and kidney transplantation in children: analysis of renal graft outcome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: October 06, 2015
Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome.
Journal: Developmental medicine and child neurology
Published: March 14, 2013
17q12 microdeletion syndrome: three patients illustrating the phenotypic spectrum.
Journal: American journal of medical genetics. Part A
Published: October 12, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026